Company intelligence / Profile preview
Antria, Inc.
Indiana, Pennsylvania, United Statesantria.org ↗
- Ownership
- Public · ANTB
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Antria specializes in developing innovative cellular therapies for cosmetic and chronic disease indications. The company provides clinical research, drug discovery, and medical device development services. No detailed public data on proprietary clinical results or pipeline stages was found[1][2][3][4].
- Therapeutic areas
- OtherDermatology
- Modalities
- Cellular therapies (cell-based therapies)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborates with sponsors, CROs, medical centers, and pharmaceutical companies (specific partners not named)[4]
04
Financials
- Market cap
- $60.5M
- Total revenue
- $0
- Enterprise value
- $-47.2M
Beyond the preview
Go deeper on Antria, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antria, Inc..